Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
March 28, 2014
Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
Mauro Rigato, Gian Paolo Fadini
Current Medicinal Chemistry
|
September 22, 2017
Circulating Stem/Progenitor Cells as Prognostic Biomarkers in Macro- and Microvascular Disease: A Narrative Review of Prospective Observational Studies
Mauro Rigato, Gian Paolo Fadini
Circulation Research
|
April 14, 2016
Levels of Circulating Progenitor Cells, Cardiovascular Outcomes and Death: A Meta-Analysis of Prospective Observational Studies
Mauro Rigato, Angelo Avogaro, Gian Paolo Fadini
Circulation Research
|
January 19, 2017
Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies
Mauro Rigato, Matteo Monami, Gian Paolo Fadini
Diabetes, Obesity & Metabolism
|
July 4, 2023
Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Mauro Rigato, Gian Paolo Fadini, Angelo Avogaro
Diabetes Research and Clinical Practice
|
March 3, 2009
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia
Gian Paolo Fadini, Mauro Rigato, Antonio Tiengo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 6, 2015
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients
Mauro Rigato, Cristina Bittante, Mattia Albiero, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 10, 2020
Effects of Basal Insulin on Lipid Profile Compared to Other Classes of Antihyperglycemic Agents in Type 2 Diabetic Patients
Mauro Rigato, Angelo Avogaro, Saula Vigili de Kreutzenberg, et al.
Diabetes, Obesity & Metabolism
|
October 21, 2017
Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors
Gian Paolo Fadini, Benedetta Maria Bonora, Sarangdhar Mayur, et al.
Diabetes Care
|
November 6, 2016
Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes
Gian Paolo Fadini, Mauro Rigato, Roberta Cappellari, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
March 28, 2014
Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
Mauro Rigato, Gian Paolo Fadini
Current Medicinal Chemistry
|
September 22, 2017
Circulating Stem/Progenitor Cells as Prognostic Biomarkers in Macro- and Microvascular Disease: A Narrative Review of Prospective Observational Studies
Mauro Rigato, Gian Paolo Fadini
Circulation Research
|
April 14, 2016
Levels of Circulating Progenitor Cells, Cardiovascular Outcomes and Death: A Meta-Analysis of Prospective Observational Studies
Mauro Rigato, Angelo Avogaro, Gian Paolo Fadini
Circulation Research
|
January 19, 2017
Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies
Mauro Rigato, Matteo Monami, Gian Paolo Fadini
Diabetes, Obesity & Metabolism
|
July 4, 2023
Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Mauro Rigato, Gian Paolo Fadini, Angelo Avogaro
Diabetes Research and Clinical Practice
|
March 3, 2009
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia
Gian Paolo Fadini, Mauro Rigato, Antonio Tiengo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 6, 2015
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients
Mauro Rigato, Cristina Bittante, Mattia Albiero, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 10, 2020
Effects of Basal Insulin on Lipid Profile Compared to Other Classes of Antihyperglycemic Agents in Type 2 Diabetic Patients
Mauro Rigato, Angelo Avogaro, Saula Vigili de Kreutzenberg, et al.
Diabetes, Obesity & Metabolism
|
October 21, 2017
Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors
Gian Paolo Fadini, Benedetta Maria Bonora, Sarangdhar Mayur, et al.
Diabetes Care
|
November 6, 2016
Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes
Gian Paolo Fadini, Mauro Rigato, Roberta Cappellari, et al.
Page
of 3